Dova Pharmaceuticals Reports First Quarter 2019 Operating and Financial Results

NEXT STORY
Prospective Data Demonstrates Effective Pain Relief and Improved Function Using Medtronic’s Evolve(SM) Workflow with Spinal Cord Stimulation
PREV STORY
RedHill Biopharma Submits New Drug Application for Talicia® for H. pylori Infection
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Leap Therapeutics To Present at 19th Annual BIO CEO & Investor Conference

CAMBRIDGE, Mass., Feb. 09, 2017 (GLOBE NEWSWIRE) -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology ...

author_avatar
NASDAQ Market News

Madrigal Pharmaceuticals Initiates Phase 3, Multinational, Double-Blind, Randomized, Placebo-Controlled Study of MGL-3196 (resmetirom) in Patients With Non-Alcoholic Steatohepatitis (NASH) and Fibrosis to Resolve NASH and Reduce Progression to Cirrhosis and/or Hepatic Decompensation

author_avatar
NASDAQ Market News

Assembly Biosciences Appoints Jackie Papkoff, PhD, Senior Vice President, Chief Scientific Officer Microbiome

INDIANAPOLIS and SAN FRANCISCO, April 02, 2018 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ:ASMB), ...

author_avatar
NASDAQ Market News